Trends in vaccine-preventable diseases in Europe
The Annual Epidemiological Report 2014 for vaccine-preventable diseases provides a snapshot of the epidemiological situation in Europe
Mumps: Burden of disease in France
Mumps is not a notifiable disease in France, and this study provides useful information by combining different data sources. The current incidence of mumps is somewhat higher than the average European (9 versus 3.2 per 100 000 per year) and authors sugges
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for Seronegativity
This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?
Despite long-standing mumps vaccination programmes with high coverage in Europe, a majority of the countries analysed have in recent years experienced mumps outbreaks
Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008
In this study, the authors have combined a household method and a school study design to assess VE against mumps as well as VE against mumps infectiousness by comparing secondary attack rates in households of vaccinated and unvaccinated cases.